Danda Trouve Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Danda Trouve Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Hold	1	–	–	﹤0.01%	125
2022 Q2	$0	Sell	1 -5	-83%	-$594	﹤0.01%	110
2022 Q1	$1K	Sell	6 -8,753	-100%	-$1.14M	﹤0.01%	108
2021 Q4	$1.34M	Sell	8,759 -2	-0%	-$310	1.51%	19
2021 Q3	$1.42M	Buy	8,761 +524	+6%	+$88.2K	1.71%	21
2021 Q2	$1.35M	Sell	8,237 -43	-0.5%	-$6.62K	1.6%	24
2021 Q1	$1.25M	Sell	8,280 -31	-0.4%	-$4.92K	1.54%	25
2020 Q4	$1.26M	Buy	8,311 +378	+5%	+$54K	1.54%	23
2020 Q3	$1.07M	Sell	7,933 -152	-2%	-$20.6K	1.46%	23
2020 Q2	$1.1M	Buy	8,085 +82	+1%	+$10.5K	1.67%	20
2020 Q1	$862K	Buy	8,003 +410	+5%	+$47.2K	1.79%	18
2019 Q4	$915K	Buy	+7,593	New	+$847K	1.32%	23

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Danda Trouve Investment Management's IBB Position: Q3 2022 in Review

Danda Trouve Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2022 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #125.

Danda Trouve Investment Management first reported a position in IBB in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.42M in Q3 2021. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Danda Trouve Investment Management held 1 share of iShares Biotechnology ETF worth $0 as of Q3 2022.
Danda Trouve Investment Management left its iShares Biotechnology ETF share count unchanged in Q3 2022.
iShares Biotechnology ETF made up ﹤0.01% of Danda Trouve Investment Management's portfolio in Q3 2022, its #125 holding.
Danda Trouve Investment Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 12 quarters since.
Danda Trouve Investment Management's iShares Biotechnology ETF position peaked at $1.42M in Q3 2021.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Danda Trouve Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.